New inhaled treatment tested for Life-Threatening lung failure
NCT ID NCT07317050
Summary
This study is testing whether an inhaled drug called aprotinin can help adults with severe lung failure (ARDS) breathe without a ventilator and survive. It will involve 156 critically ill patients in intensive care units who will receive either the drug or a placebo, in addition to standard care. The main goal is to see if the drug improves the combined outcome of survival and the number of days patients can breathe on their own within 28 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital General Universitario de Ciudad Real
Ciudad Real, Ciudad Real, 13005, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.